Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)Tobias Welte, Antoní Torres, R. Phillip Dellinger et al.|Intensive Care Medicine|2018Cited by 136
Advances in the critical care management for patients with hematological malignanciesÉlie Azoulay, Ignacio Martín‐Loeches, Dara Chean et al.|Blood Reviews|2025Cited by 12